Advanced Autoantibody Testing in Systemic Sclerosis-Reference-Cited by-同舟云学术

Advanced Autoantibody Testing in Systemic Sclerosis

Published:2023-02-23 Issue:5 Volume:13 Page:851
ISSN:2075-4418
Container-title:Diagnostics
language:en
Short-container-title:Diagnostics

Author:

Almaabdi Kholoud¹,Ahmad Zareen¹,Johnson Sindhu R.¹²³^ORCID

Affiliation:

1. Toronto Scleroderma Program, Division of Rheumatology, Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, ON M5T 1R8, Canada

2. Toronto Scleroderma Program, Schroeder Arthritis Institute, Division of Rheumatology, Department of Medicine, Toronto Western Hospital, Toronto, ON M5T 379, Canada

3. Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, ON M5T 3M6, Canada

Abstract

Systemic sclerosis is a systemic autoimmune rheumatic disease characterized by immune abnormalities, leading to vasculopathy and fibrosis. Autoantibody testing has become an increasingly important part of diagnosis and prognostication. Clinicians have been limited to antinuclear antibody (ANA), antitopoisomerase I (also known as anti-Scl-70) antibody, and anticentromere antibody testing. Many clinicians now have improved access to an expanded profile of autoantibody testing. In this narrative review article, we review the epidemiology, clinical associations, and prognostic value of advanced autoantibody testing in people with systemic sclerosis.

Publisher

MDPI AG

Subject

Clinical Biochemistry

Link

https://www.mdpi.com/2075-4418/13/5/851/pdf

Reference91 articles.

1. Predictors of progression in systemic sclerosis patients with interstitial lung disease;Distler;Eur. Respir. J.,2020

2. Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: A pilot study;Ruaro;Rheumatol. Int.,2019

3. Caforio, A.L.P., De Luca, G., Baritussio, A., Seguso, M., Gallo, N., Bison, E., Cattini, M.G., Pontara, E., Gargani, L., and Pepe, A. (2021). Serum Organ-Specific Anti-Heart and Anti-Intercalated Disk Autoantibodies as New Autoimmune Markers of Cardiac Involvement in Systemic Sclerosis: Frequency, Clinical and Prognostic Correlates. Diagnostics, 11.

4. Ruaro, B., Baratella, E., Confalonieri, P., Wade, B., Marrocchio, C., Geri, P., Busca, A., Pozzan, R., Andrisano, A.G., and Cova, M.A. (2021). High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients. Diagnostics, 11.

5. Incidence and prevalence of systemic sclerosis globally: A comprehensive systematic review and meta-analysis;Bairkdar;Rheumatology,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reproducibility of pulmonary function tests in patients with systemic sclerosis;Scientific Reports;2023-11-03

2. A Multidisciplinary Approach as a Goal for the Management of Complications in Systemic Scleroderma: A Literature Review and Case Scenario;Diagnostics;2023-10-28

3. Biomarkers in Systemic Sclerosis: An Overview;Current Issues in Molecular Biology;2023-09-25

4. The significance of dense fine speckled pattern in antinuclear antibody‐associated rheumatic disease and coexisting autoantibodies: A propensity score‐matched cohort study;International Journal of Rheumatic Diseases;2023-06-20

5. Incidence and Predictors of an Abnormal Liver Function Test Among 674 Systemic Sclerosis Patients: A Cohort Study;Open Access Rheumatology: Research and Reviews;2023-05